Net shares · 365d
-190.1K
0 buy · 190.1K sell
Net value · 365d
-$344.2K
$0 in · $344.2K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
8
0 buy · 190.1K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
BYSI Sell·S
TenPercentOwner
$227.7K
131.3K sh · $1.73 avg · 2 lots
Own -8%
-
BYSI Sell·S
TenPercentOwner
$7.4K
4.1K sh · $1.79 avg · 3 lots
Own -0%
-
BYSI Sell·S
TenPercentOwner
$109.2K
54.7K sh · $1.99 avg · 3 lots
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Oct 17, 2025 | BYSI | Sell S | 131.3K · 2 lots | $227.7K |
| Aug 28, 2025 | BYSI | Sell S | 4.1K · 3 lots | $7.4K |
| Aug 20, 2025 | BYSI | Sell S | 54.7K · 3 lots | $109.2K |
Buy Sell Non-market (grant · exercise · gift)
About Decheng Capital China Life Sciences USD Fund II, L.P.
This profile aggregates every SEC Form 4 insider transaction reported by Decheng Capital China Life Sciences USD Fund II, L.P. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.